Skip to main content
. 2021 Jul 27;36(2):395–403. doi: 10.1007/s12028-021-01305-1

Table 1.

Characteristics of 211 patients with ICH in Tibet

Variables Study participants (n = 211)
Age, mean ± SD (year) 58.34 ± 12.08
Male sex [n (%)] 142 (67.3)
BMI, median (IQR) (kg/m2) 23.39 (22.26–24.66)
Smoking history [n (%)] 38 (18.0)
Alcohol history [n (%)] 27 (12.8)
Hypertension [n (%)] 151 (71.6)
Diabetes mellitus [n (%)] 3 (1.4)
Coronary heart disease [n (%)] 13 (6.2)
Stroke history [n (%)] 17 (8.1)
Antithrombotic agent history [n (%)] 6 (2.8)
The degree of coma (GCS score) [n (%)]
 Level 1 (13–15 points) 96 (45.5)
 Level 2 (9–12 points) 41 (19.4)
 Level 3 (3–8 points) 74 (35.1)
Supratentorial hemorrhage [n (%)]
 Basal ganglia 82 (38.9)
 Lobar 66 (31.3)
 Thalamus 54 (25.6)
Infratentorial hemorrhage [n (%)]
 Brainstem 16 (7.6)
 Cerebellum 14 (6.6)
IVH [n (%)] 106 (50.2)
SAH [n (%)] 35 (16.6)
 Large hematoma [n (%)] 88 (41.7)
 Hematoma volume, median (IQR) (ml) 18.50 (7.94–43.70)
Hematoma volume at various hemorrhagic locations
 Basal ganglia, median (IQR) (ml) 24.38 (12.86–50.40)
 Lobar, median (IQR) (ml) 22.33 (9.64–47.63)
 Thalamus, median (IQR) (ml) 17.72 (7.34–43.53)
 Brainstem, median (IQR) (ml) 7.05 (2.86–15.34)
 Cerebellum, median (IQR) (ml) 11.25 (5.91–25.22)
Laboratory examination
 TG, median (IQR) (mmol/l) 0.95 (0.73–1.36)
 HDL, mean ± SD (mmol/l) 1.21 ± 0.34
 LDL, mean ± SD (mmol/l) 2.43 ± 0.91
 TC, mean ± SD (mmol/l) 4.07 ± 1.11
 Hemoglobin, mean ± SD (g/l) 165.03 ± 34.12
 Platelet count, mean ± SD (109/l) 188.31 ± 71.49
 Surgical operation [n (%)] 45 (21.3)
 mRS 4–6 [n (%)] 89 (42.2)

BMI Body mass index, GCS Glasgow Coma Scale, HDL high-density lipoprotein cholesterol, ICH intracerebral hemorrhage, IQR interquartile range, IVH intraventricular hemorrhage, LDL low-density lipoprotein cholesterol, mRS Modified Rankin Scale, SAH subarachnoid hemorrhage, SD standard deviation, TC total cholesterol, TG triglycerides